Novartis CCTL019C2201; HM2015-13: A phase II, single arm

Project: Research project

Project Details

Description

Novartis CCTL019C2201; HM2015-13: A phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
StatusActive
Effective start/end date4/10/156/14/22

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.